Additionally, Wei et al. [46] reported that the promoter region methylation status of suppressor of cytokine signaling 3 (SOCS3) was associated with AFP, tumor size, and the degree of tumor differentiation, serving as a biomarker for a poor HCC prognosis. The gene discussed is AFP; the disease is neoplasm.